Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sodium Sulfide 1% Gel Safety Supported By New Clinical Data - Schering

This article was originally published in The Tan Sheet

Executive Summary

The safety of sodium sulfide gel for the relief of pain associated with ingrown toenails is exhibited by the results of a clinical study conducted by Schering-Plough, the company tells FDA in an Oct. 13 citizen petition. Previous agency concerns regarding the ingredient's safety should be addressed by the findings, the petition says.
Advertisement

Related Content

Sodium Sulfide 1% Gel Ingrown Toenail Safety Shown By Schering-Plough
Sodium Sulfide 1% Gel Ingrown Toenail Safety Shown By Schering-Plough
Sodium Sulfide 1% Gel Ingrown Toenail Safety Shown By Schering-Plough

Topics

Advertisement
UsernamePublicRestriction

Register

PS089063

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel